University of Maryland School of Medicine, Baltimore, MD, United States of America.
Veterans Affairs Maryland Health Care System, Baltimore, MD, United States of America.
PLoS One. 2020 Dec 11;15(12):e0237033. doi: 10.1371/journal.pone.0237033. eCollection 2020.
The preponderance of evidence from recent studies in human subjects supports a negative effect of the BDNF Val66Met polymorphism on motor outcomes and motor recovery. However prior studies have generally reported the effect of the Met allele in older stroke patients, while potential effects in younger stroke patients have remained essentially unexamined. The lack of research in younger patients is significant since aging effects on CNS repair and functional recovery after stroke are known to interact with the effects of genetic polymorphisms. Here we present a study of first-ever ischemic stroke patients aged 15-49 years that examines the effect of Met carrier status on functional disability.
829 patients with a first ischemic stroke (Average age = 41.4 years, SD = 6.9) were recruited from the Baltimore-Washington region. Genotyping was performed at the Johns Hopkins University Center for Inherited Disease Research (CIDR). Data cleaning and harmonization were done at the GEI-funded GENEVA Coordinating Center at the University of Washington. Our sample contained 165 Met carriers and 664 non-Met carriers. Modified Rankin scores as recorded at discharge were obtained from the hospital records by study personnel blinded to genotype, and binarized into "Good" versus "Poor" outcomes (mRS 0-2 vs. 3+), with mRS scores 3+ reflecting a degree of disability that causes loss of independence.
Our analysis showed that the Met allele conveyed a proportionally greater risk for poor outcomes and disability-related loss of independence with mRS scores 3+ (adjusted OR 1.73, 95% CI 1.13-2.64, p = 0.01).
The BDNF Val66Met polymorphism was negatively associated with functional outcomes at discharge in our sample of 829 young stroke patients. This finding stands in contrast to what would be predicted under the tenets of the resource modulation hypothesis (i.e. that younger patients would be spared from the negative effect of the Met allele on recovery since it is posited to arise as a manifestation of age-related decline in physiologic resources).
最近对人类受试者进行的大量研究结果表明,BDNF Val66Met 多态性对运动结局和运动恢复有负面影响。然而,先前的研究通常报告了 Met 等位基因在老年中风患者中的作用,而年轻中风患者的潜在作用基本上没有得到研究。由于已知衰老对中枢神经系统修复和中风后功能恢复的影响与遗传多态性的影响相互作用,因此在年轻患者中进行研究具有重要意义。在这里,我们介绍了一项针对年龄在 15-49 岁的首次缺血性中风患者的研究,该研究检查了 Met 携带者状态对功能障碍的影响。
从巴尔的摩-华盛顿地区招募了 829 名首次缺血性中风患者(平均年龄=41.4 岁,标准差=6.9)。基因分型在约翰霍普金斯大学遗传性疾病研究中心(CIDR)进行。数据清理和协调在华盛顿大学由 GENEVA 协调中心在 GEI 资助下进行。我们的样本包含 165 名 Met 携带者和 664 名非 Met 携带者。研究人员通过对基因型不知情的方式从医院记录中获得出院时的改良 Rankin 评分,并将其分为“良好”与“不良”结局(mRS 0-2 与 3+),mRS 评分 3+表示残疾程度导致丧失独立性。
我们的分析表明,Met 等位基因与不良结局和与残疾相关的 mRS 评分 3+的独立性丧失呈比例关系更大(调整后的 OR 1.73,95%CI 1.13-2.64,p=0.01)。
在我们的 829 名年轻中风患者样本中,BDNF Val66Met 多态性与出院时的功能结局呈负相关。这一发现与资源调节假说的原则相反(即年轻患者不会免受 Met 等位基因对恢复的负面影响,因为它被认为是与年龄相关的生理资源下降有关的表现)。